World Health Assembly: WHO To Member States: Support Our Efforts Vs. Substandard, Fake Medicines 22/05/2014 by William New, Intellectual Property Watch Leave a Comment World Health Organization members this week will decide on approval of a work plan on poor quality medicines, and the WHO secretariat is hoping members will follow with financial support to carry out the plan.
Vaccines At WHA: Immunization Concerns, High Prices For Middle-Income Countries 22/05/2014 by Catherine Saez, Intellectual Property Watch 4 Comments Immunization coverage in many developing countries remains low and even shows a decrease in some cases, according to the report of a World Health Organization advisory group of experts, to be noted by this week’s World Health Assembly. A number of developing countries yesterday underlined the high cost of new vaccines and asked that the WHO help them campaign for lower prices.
World Health Assembly Approves Resolution On Combatting Tuberculosis 22/05/2014 by Joséphine De Ruyck for Intellectual Property Watch Leave a Comment The World Health Assembly on 21 May approved a resolution on global strategy and targets for tuberculosis prevention, care and control after 2015, which includes a new multisectoral strategic approach and bold targets to bring an end to the global epidemic by 2035.
World Health Assembly: Panels Discuss Diagnostics, Surveillance, R&D Models For Antibiotic Resistance 22/05/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment Multiple stakeholders are pushing for a World Health Organization-led global action plan to curb antimicrobial resistance.
New WHO Document On Neglected Disease R&D Model Projects 21/05/2014 by Intellectual Property Watch Leave a Comment A new document on efforts to find innovative financing for neglected diseases has been made available today at the World Health Assembly.
Role Of Industry, NGOs, Foundations At WHO Under Intense Debate 21/05/2014 by Catherine Saez, Intellectual Property Watch 1 Comment A proposal to increase the engagement of “non-state actors” – industry, nongovernmental organisations, foundations and academics – in the activities of the World Health Organization is under intense debate at the annual World Health Assembly this week.
Author Interview: “Emerging Markets And The World Patent Order” 21/05/2014 by Intellectual Property Watch Leave a Comment “Emerging Markets and the World Patent Order” is a new book that looks at patent system implementation in emerging market and developing countries, and the response to this implementation by Europe and the United States. Florida State University Law Prof. Frederick Abbott, one of the organisers and editors of the book, recently discussed the book with Intellectual Property Watch
Sanofi-WHO Partnership Could Eliminate Sleeping Sickness By 2020 21/05/2014 by William New, Intellectual Property Watch Leave a Comment A side event to this week’s World Health Assembly highlighted progress being made in a public-private partnership on the elimination of sleeping sickness, a disease that occurs in some developing countries.
Gates Foundation Echoes WHO Concern Over Medicines Access In Trade Deals 20/05/2014 by William New, Intellectual Property Watch 1 Comment Melinda Gates of the Bill & Melinda Gates Foundation addressed the World Health Assembly today, highlighting a new initiative on newborns. And at a press conference earlier in the day, a senior colleague signalled support for WHO Director General Margaret Chan’s strong concern yesterday about possible negative effects of free trade agreements on access to affordable medicines.
BRICS Ministers Join Forces For Access To Medicines 20/05/2014 by Julia Fraser for Intellectual Property Watch 1 Comment At a side event to the opening of the 2014 World Health Assembly, strong statements were made by BRICS (Brazil, Russia, India, China and South Africa) country ministers and representatives to assume leadership and cooperate to tackle the issue of inaccessibility to affordable medicines in theirs and developing countries.